 | • レポートコード：MRC2-11QY04291 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は血小板・血漿のグローバル市場について調査・分析したレポートです。種類別（血小板、血漿）市場規模、用途別（血友病、血小板減少症、周術期適応症、血小板機能障害、凝固因子欠損症、血栓性血小板減少性紫斑病、出血、肝疾患）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別血小板・血漿の競争状況、市場シェア ・世界の血小板・血漿市場：種類別市場規模 2015年-2020年（血小板、血漿） ・世界の血小板・血漿市場：種類別市場規模予測 2021年-2026年（血小板、血漿） ・世界の血小板・血漿市場：用途別市場規模 2015年-2020年（血友病、血小板減少症、周術期適応症、血小板機能障害、凝固因子欠損症、血栓性血小板減少性紫斑病、出血、肝疾患） ・世界の血小板・血漿市場：用途別市場規模予測 2021年-2026年（血友病、血小板減少症、周術期適応症、血小板機能障害、凝固因子欠損症、血栓性血小板減少性紫斑病、出血、肝疾患） ・北米の血小板・血漿市場分析：米国、カナダ ・ヨーロッパの血小板・血漿市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの血小板・血漿市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の血小板・血漿市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの血小板・血漿市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：America’s Blood Centers、American Red Cross、American Association of Blood Banks、Blood Centers of America、Brazilian Red Cross、Canadian Red Cross、European Blood Alliance、French Red Cross、German Red Cross、Indian Red Cross、Italian Red Cross、Red Cross Society of China、Saudi Red Crescent Authority、South African Red Cross Society ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Platelets, also called thrombocytes, are a component of blood whose function (along with the coagulation factors) is to react to bleeding from blood vessel injury by clumping, thereby initiating a blood clot. Plasma is a yellowish coloured liquid component of blood that normally holds the blood cells in whole blood in suspension; this makes plasma the extracellular matrix of blood cells.
Platelets have no cell nucleus: they are fragments of cytoplasm that are derived from the megakaryocytes of the bone marrow, and then enter the circulation. Circulating unactivated platelets are biconvex discoid (lens-shaped) structures,2–3 µm in greatest diameter. Platelets are found only in mammals, whereas in other animals (e.g. birds, amphibians) thrombocytes circulate as intact mononuclear cells. Plasma makes up about 55% of the body’s total blood volume.It is the intravascular fluid part of extracellular fluid (all body fluid outside cells). It is mostly water (up to 95% by volume), and contains dissolved proteins (6–8%) (i.e.—serum albumins, globulins, and fibrinogen), glucose, clotting factors, electrolytes (Na+, Ca2+, Mg2+, HCO3−, Cl−, etc.), hormones, carbon dioxide (plasma being the main medium for excretory product transportation) and oxygen. Plasma also serves as the protein reserve of the human body. It plays a vital role in an intravascular osmotic effect that keeps electrolytes in balanced form and protects the body from infection and other blood disorders. Rising prevalence of chronic diseases such as haemophilia, thrombocytopenia, haemorrhage, liver diseases as well as other rare and infectious diseases will drive the global platelet and plasma market.
Market Analysis and Insights: Global Platelet and Plasma Market
The global Platelet and Plasma market size is projected to reach US$ 5238.3 million by 2026, from US$ 5159.3 million in 2020, at a CAGR of 1.4%% during 2021-2026.
Global Platelet and Plasma Scope and Market Size
Platelet and Plasma market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Platelet and Plasma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
America’s Blood Centers
American Red Cross
American Association of Blood Banks
Blood Centers of America
Brazilian Red Cross
Canadian Red Cross
European Blood Alliance
French Red Cross
German Red Cross
Indian Red Cross
Italian Red Cross
Red Cross Society of China
Saudi Red Crescent Authority
South African Red Cross Society
Market segment by Type, the product can be split into
Platelet
Plasma
Market segment by Application, split into
Hemophilia
Thrombocytopenia
Perioperative Indications
Platelet Function Disorders
Other Platelet Applications
Coagulation Factor Deficiencies
Thrombotic Thrombocytopenic Purpura
Hemorrhage
Liver Disease
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Platelet and Plasma Revenue
1.4 Market by Type
1.4.1 Global Platelet and Plasma Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Platelet
1.4.3 Plasma
1.5 Market by Application
1.5.1 Global Platelet and Plasma Market Share by Application: 2020 VS 2026
1.5.2 Hemophilia
1.5.3 Thrombocytopenia
1.5.4 Perioperative Indications
1.5.5 Platelet Function Disorders
1.5.6 Other Platelet Applications
1.5.7 Coagulation Factor Deficiencies
1.5.8 Thrombotic Thrombocytopenic Purpura
1.5.9 Hemorrhage
1.5.10 Liver Disease
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Platelet and Plasma Market Perspective (2015-2026)
2.2 Global Platelet and Plasma Growth Trends by Regions
2.2.1 Platelet and Plasma Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Platelet and Plasma Historic Market Share by Regions (2015-2020)
2.2.3 Platelet and Plasma Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Platelet and Plasma Market Growth Strategy
2.3.6 Primary Interviews with Key Platelet and Plasma Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Platelet and Plasma Players by Market Size
3.1.1 Global Top Platelet and Plasma Players by Revenue (2015-2020)
3.1.2 Global Platelet and Plasma Revenue Market Share by Players (2015-2020)
3.1.3 Global Platelet and Plasma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Platelet and Plasma Market Concentration Ratio
3.2.1 Global Platelet and Plasma Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Platelet and Plasma Revenue in 2019
3.3 Platelet and Plasma Key Players Head office and Area Served
3.4 Key Players Platelet and Plasma Product Solution and Service
3.5 Date of Enter into Platelet and Plasma Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Platelet and Plasma Historic Market Size by Type (2015-2020)
4.2 Global Platelet and Plasma Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Platelet and Plasma Market Size by Application (2015-2020)
5.2 Global Platelet and Plasma Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Platelet and Plasma Market Size (2015-2020)
6.2 Platelet and Plasma Key Players in North America (2019-2020)
6.3 North America Platelet and Plasma Market Size by Type (2015-2020)
6.4 North America Platelet and Plasma Market Size by Application (2015-2020)
7 Europe
7.1 Europe Platelet and Plasma Market Size (2015-2020)
7.2 Platelet and Plasma Key Players in Europe (2019-2020)
7.3 Europe Platelet and Plasma Market Size by Type (2015-2020)
7.4 Europe Platelet and Plasma Market Size by Application (2015-2020)
8 China
8.1 China Platelet and Plasma Market Size (2015-2020)
8.2 Platelet and Plasma Key Players in China (2019-2020)
8.3 China Platelet and Plasma Market Size by Type (2015-2020)
8.4 China Platelet and Plasma Market Size by Application (2015-2020)
9 Japan
9.1 Japan Platelet and Plasma Market Size (2015-2020)
9.2 Platelet and Plasma Key Players in Japan (2019-2020)
9.3 Japan Platelet and Plasma Market Size by Type (2015-2020)
9.4 Japan Platelet and Plasma Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Platelet and Plasma Market Size (2015-2020)
10.2 Platelet and Plasma Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Platelet and Plasma Market Size by Type (2015-2020)
10.4 Southeast Asia Platelet and Plasma Market Size by Application (2015-2020)
11 India
11.1 India Platelet and Plasma Market Size (2015-2020)
11.2 Platelet and Plasma Key Players in India (2019-2020)
11.3 India Platelet and Plasma Market Size by Type (2015-2020)
11.4 India Platelet and Plasma Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Platelet and Plasma Market Size (2015-2020)
12.2 Platelet and Plasma Key Players in Central & South America (2019-2020)
12.3 Central & South America Platelet and Plasma Market Size by Type (2015-2020)
12.4 Central & South America Platelet and Plasma Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 America’s Blood Centers
13.1.1 America’s Blood Centers Company Details
13.1.2 America’s Blood Centers Business Overview
13.1.3 America’s Blood Centers Platelet and Plasma Introduction
13.1.4 America’s Blood Centers Revenue in Platelet and Plasma Business (2015-2020))
13.1.5 America’s Blood Centers Recent Development
13.2 American Red Cross
13.2.1 American Red Cross Company Details
13.2.2 American Red Cross Business Overview
13.2.3 American Red Cross Platelet and Plasma Introduction
13.2.4 American Red Cross Revenue in Platelet and Plasma Business (2015-2020)
13.2.5 American Red Cross Recent Development
13.3 American Association of Blood Banks
13.3.1 American Association of Blood Banks Company Details
13.3.2 American Association of Blood Banks Business Overview
13.3.3 American Association of Blood Banks Platelet and Plasma Introduction
13.3.4 American Association of Blood Banks Revenue in Platelet and Plasma Business (2015-2020)
13.3.5 American Association of Blood Banks Recent Development
13.4 Blood Centers of America
13.4.1 Blood Centers of America Company Details
13.4.2 Blood Centers of America Business Overview
13.4.3 Blood Centers of America Platelet and Plasma Introduction
13.4.4 Blood Centers of America Revenue in Platelet and Plasma Business (2015-2020)
13.4.5 Blood Centers of America Recent Development
13.5 Brazilian Red Cross
13.5.1 Brazilian Red Cross Company Details
13.5.2 Brazilian Red Cross Business Overview
13.5.3 Brazilian Red Cross Platelet and Plasma Introduction
13.5.4 Brazilian Red Cross Revenue in Platelet and Plasma Business (2015-2020)
13.5.5 Brazilian Red Cross Recent Development
13.6 Canadian Red Cross
13.6.1 Canadian Red Cross Company Details
13.6.2 Canadian Red Cross Business Overview
13.6.3 Canadian Red Cross Platelet and Plasma Introduction
13.6.4 Canadian Red Cross Revenue in Platelet and Plasma Business (2015-2020)
13.6.5 Canadian Red Cross Recent Development
13.7 European Blood Alliance
13.7.1 European Blood Alliance Company Details
13.7.2 European Blood Alliance Business Overview
13.7.3 European Blood Alliance Platelet and Plasma Introduction
13.7.4 European Blood Alliance Revenue in Platelet and Plasma Business (2015-2020)
13.7.5 European Blood Alliance Recent Development
13.8 French Red Cross
13.8.1 French Red Cross Company Details
13.8.2 French Red Cross Business Overview
13.8.3 French Red Cross Platelet and Plasma Introduction
13.8.4 French Red Cross Revenue in Platelet and Plasma Business (2015-2020)
13.8.5 French Red Cross Recent Development
13.9 German Red Cross
13.9.1 German Red Cross Company Details
13.9.2 German Red Cross Business Overview
13.9.3 German Red Cross Platelet and Plasma Introduction
13.9.4 German Red Cross Revenue in Platelet and Plasma Business (2015-2020)
13.9.5 German Red Cross Recent Development
13.10 Indian Red Cross
13.10.1 Indian Red Cross Company Details
13.10.2 Indian Red Cross Business Overview
13.10.3 Indian Red Cross Platelet and Plasma Introduction
13.10.4 Indian Red Cross Revenue in Platelet and Plasma Business (2015-2020)
13.10.5 Indian Red Cross Recent Development
13.11 Italian Red Cross
10.11.1 Italian Red Cross Company Details
10.11.2 Italian Red Cross Business Overview
10.11.3 Italian Red Cross Platelet and Plasma Introduction
10.11.4 Italian Red Cross Revenue in Platelet and Plasma Business (2015-2020)
10.11.5 Italian Red Cross Recent Development
13.12 Red Cross Society of China
10.12.1 Red Cross Society of China Company Details
10.12.2 Red Cross Society of China Business Overview
10.12.3 Red Cross Society of China Platelet and Plasma Introduction
10.12.4 Red Cross Society of China Revenue in Platelet and Plasma Business (2015-2020)
10.12.5 Red Cross Society of China Recent Development
13.13 Saudi Red Crescent Authority
10.13.1 Saudi Red Crescent Authority Company Details
10.13.2 Saudi Red Crescent Authority Business Overview
10.13.3 Saudi Red Crescent Authority Platelet and Plasma Introduction
10.13.4 Saudi Red Crescent Authority Revenue in Platelet and Plasma Business (2015-2020)
10.13.5 Saudi Red Crescent Authority Recent Development
13.14 South African Red Cross Society
10.14.1 South African Red Cross Society Company Details
10.14.2 South African Red Cross Society Business Overview
10.14.3 South African Red Cross Society Platelet and Plasma Introduction
10.14.4 South African Red Cross Society Revenue in Platelet and Plasma Business (2015-2020)
10.14.5 South African Red Cross Society Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Platelet and Plasma Key Market Segments
Table 2. Key Players Covered: Ranking by Platelet and Plasma Revenue
Table 3. Ranking of Global Top Platelet and Plasma Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Platelet and Plasma Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Platelet
Table 6. Key Players of Plasma
Table 7. Global Platelet and Plasma Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Platelet and Plasma Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Platelet and Plasma Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Platelet and Plasma Market Share by Regions (2015-2020)
Table 11. Global Platelet and Plasma Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Platelet and Plasma Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Platelet and Plasma Market Growth Strategy
Table 17. Main Points Interviewed from Key Platelet and Plasma Players
Table 18. Global Platelet and Plasma Revenue by Players (2015-2020) (Million US$)
Table 19. Global Platelet and Plasma Market Share by Players (2015-2020)
Table 20. Global Top Platelet and Plasma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Platelet and Plasma as of 2019)
Table 21. Global Platelet and Plasma by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Platelet and Plasma Product Solution and Service
Table 24. Date of Enter into Platelet and Plasma Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Platelet and Plasma Market Size by Type (2015-2020) (Million US$)
Table 27. Global Platelet and Plasma Market Size Share by Type (2015-2020)
Table 28. Global Platelet and Plasma Revenue Market Share by Type (2021-2026)
Table 29. Global Platelet and Plasma Market Size Share by Application (2015-2020)
Table 30. Global Platelet and Plasma Market Size by Application (2015-2020) (Million US$)
Table 31. Global Platelet and Plasma Market Size Share by Application (2021-2026)
Table 32. North America Key Players Platelet and Plasma Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Platelet and Plasma Market Share (2019-2020)
Table 34. North America Platelet and Plasma Market Size by Type (2015-2020) (Million US$)
Table 35. North America Platelet and Plasma Market Share by Type (2015-2020)
Table 36. North America Platelet and Plasma Market Size by Application (2015-2020) (Million US$)
Table 37. North America Platelet and Plasma Market Share by Application (2015-2020)
Table 38. Europe Key Players Platelet and Plasma Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Platelet and Plasma Market Share (2019-2020)
Table 40. Europe Platelet and Plasma Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Platelet and Plasma Market Share by Type (2015-2020)
Table 42. Europe Platelet and Plasma Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Platelet and Plasma Market Share by Application (2015-2020)
Table 44. China Key Players Platelet and Plasma Revenue (2019-2020) (Million US$)
Table 45. China Key Players Platelet and Plasma Market Share (2019-2020)
Table 46. China Platelet and Plasma Market Size by Type (2015-2020) (Million US$)
Table 47. China Platelet and Plasma Market Share by Type (2015-2020)
Table 48. China Platelet and Plasma Market Size by Application (2015-2020) (Million US$)
Table 49. China Platelet and Plasma Market Share by Application (2015-2020)
Table 50. Japan Key Players Platelet and Plasma Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Platelet and Plasma Market Share (2019-2020)
Table 52. Japan Platelet and Plasma Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Platelet and Plasma Market Share by Type (2015-2020)
Table 54. Japan Platelet and Plasma Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Platelet and Plasma Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Platelet and Plasma Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Platelet and Plasma Market Share (2019-2020)
Table 58. Southeast Asia Platelet and Plasma Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Platelet and Plasma Market Share by Type (2015-2020)
Table 60. Southeast Asia Platelet and Plasma Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Platelet and Plasma Market Share by Application (2015-2020)
Table 62. India Key Players Platelet and Plasma Revenue (2019-2020) (Million US$)
Table 63. India Key Players Platelet and Plasma Market Share (2019-2020)
Table 64. India Platelet and Plasma Market Size by Type (2015-2020) (Million US$)
Table 65. India Platelet and Plasma Market Share by Type (2015-2020)
Table 66. India Platelet and Plasma Market Size by Application (2015-2020) (Million US$)
Table 67. India Platelet and Plasma Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Platelet and Plasma Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Platelet and Plasma Market Share (2019-2020)
Table 70. Central & South America Platelet and Plasma Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Platelet and Plasma Market Share by Type (2015-2020)
Table 72. Central & South America Platelet and Plasma Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Platelet and Plasma Market Share by Application (2015-2020)
Table 74. America’s Blood Centers Company Details
Table 75. America’s Blood Centers Business Overview
Table 76. America’s Blood Centers Product
Table 77. America’s Blood Centers Revenue in Platelet and Plasma Business (2015-2020) (Million US$)
Table 78. America’s Blood Centers Recent Development
Table 79. American Red Cross Company Details
Table 80. American Red Cross Business Overview
Table 81. American Red Cross Product
Table 82. American Red Cross Revenue in Platelet and Plasma Business (2015-2020) (Million US$)
Table 83. American Red Cross Recent Development
Table 84. American Association of Blood Banks Company Details
Table 85. American Association of Blood Banks Business Overview
Table 86. American Association of Blood Banks Product
Table 87. American Association of Blood Banks Revenue in Platelet and Plasma Business (2015-2020) (Million US$)
Table 88. American Association of Blood Banks Recent Development
Table 89. Blood Centers of America Company Details
Table 90. Blood Centers of America Business Overview
Table 91. Blood Centers of America Product
Table 92. Blood Centers of America Revenue in Platelet and Plasma Business (2015-2020) (Million US$)
Table 93. Blood Centers of America Recent Development
Table 94. Brazilian Red Cross Company Details
Table 95. Brazilian Red Cross Business Overview
Table 96. Brazilian Red Cross Product
Table 97. Brazilian Red Cross Revenue in Platelet and Plasma Business (2015-2020) (Million US$)
Table 98. Brazilian Red Cross Recent Development
Table 99. Canadian Red Cross Company Details
Table 100. Canadian Red Cross Business Overview
Table 101. Canadian Red Cross Product
Table 102. Canadian Red Cross Revenue in Platelet and Plasma Business (2015-2020) (Million US$)
Table 103. Canadian Red Cross Recent Development
Table 104. European Blood Alliance Company Details
Table 105. European Blood Alliance Business Overview
Table 106. European Blood Alliance Product
Table 107. European Blood Alliance Revenue in Platelet and Plasma Business (2015-2020) (Million US$)
Table 108. European Blood Alliance Recent Development
Table 109. French Red Cross Business Overview
Table 110. French Red Cross Product
Table 111. French Red Cross Company Details
Table 112. French Red Cross Revenue in Platelet and Plasma Business (2015-2020) (Million US$)
Table 113. French Red Cross Recent Development
Table 114. German Red Cross Company Details
Table 115. German Red Cross Business Overview
Table 116. German Red Cross Product
Table 117. German Red Cross Revenue in Platelet and Plasma Business (2015-2020) (Million US$)
Table 118. German Red Cross Recent Development
Table 119. Indian Red Cross Company Details
Table 120. Indian Red Cross Business Overview
Table 121. Indian Red Cross Product
Table 122. Indian Red Cross Revenue in Platelet and Plasma Business (2015-2020) (Million US$)
Table 123. Indian Red Cross Recent Development
Table 124. Italian Red Cross Company Details
Table 125. Italian Red Cross Business Overview
Table 126. Italian Red Cross Product
Table 127. Italian Red Cross Revenue in Platelet and Plasma Business (2015-2020) (Million US$)
Table 128. Italian Red Cross Recent Development
Table 129. Red Cross Society of China Company Details
Table 130. Red Cross Society of China Business Overview
Table 131. Red Cross Society of China Product
Table 132. Red Cross Society of China Revenue in Platelet and Plasma Business (2015-2020) (Million US$)
Table 133. Red Cross Society of China Recent Development
Table 134. Saudi Red Crescent Authority Company Details
Table 135. Saudi Red Crescent Authority Business Overview
Table 136. Saudi Red Crescent Authority Product
Table 137. Saudi Red Crescent Authority Revenue in Platelet and Plasma Business (2015-2020) (Million US$)
Table 138. Saudi Red Crescent Authority Recent Development
Table 139. South African Red Cross Society Company Details
Table 140. South African Red Cross Society Business Overview
Table 141. South African Red Cross Society Product
Table 142. South African Red Cross Society Revenue in Platelet and Plasma Business (2015-2020) (Million US$)
Table 143. South African Red Cross Society Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Platelet and Plasma Market Share by Type: 2020 VS 2026
Figure 2. Platelet Features
Figure 3. Plasma Features
Figure 4. Global Platelet and Plasma Market Share by Application: 2020 VS 2026
Figure 5. Hemophilia Case Studies
Figure 6. Thrombocytopenia Case Studies
Figure 7. Perioperative Indications Case Studies
Figure 8. Platelet Function Disorders Case Studies
Figure 9. Other Platelet Applications Case Studies
Figure 10. Coagulation Factor Deficiencies Case Studies
Figure 11. Thrombotic Thrombocytopenic Purpura Case Studies
Figure 12. Hemorrhage Case Studies
Figure 13. Liver Disease Case Studies
Figure 14. Platelet and Plasma Report Years Considered
Figure 15. Global Platelet and Plasma Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Platelet and Plasma Market Share by Regions: 2020 VS 2026
Figure 17. Global Platelet and Plasma Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Platelet and Plasma Market Share by Players in 2019
Figure 20. Global Top Platelet and Plasma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Platelet and Plasma as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Platelet and Plasma Revenue in 2019
Figure 22. North America Platelet and Plasma Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Platelet and Plasma Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Platelet and Plasma Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Platelet and Plasma Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Platelet and Plasma Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Platelet and Plasma Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Platelet and Plasma Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed
多血小板血漿の世界市場（～2026年） Platelet rich plasma (PRP) is a blood plasma product in which concentration of platelets is elevated four to eight times than normal blood platelet concentration.PRP is also called platelet rich gel, platelet enriched plasma and platelet enriched gel. Market Analysis and Insights: Global Platelet Ri…- スキンリプレイスメントの世界市場（～2026年） Skin replacement represents a prospective source of advanced therapy in combating acute and chronic skin wounds. Increased life expectancy, increasing disposable income and favorable demographics are some of the key factors driving the growth of the global skin replacement market. Market Analysis an…
- 治療用血漿交換の世界市場（～2026年） Plasma exchange is a procedure that separates and removes plasma from the blood in order to eliminate a disease substance circulating in the plasma. The red blood cells, white blood cells, and platelets are returned to the patient, along with a prescribed replacement fluid. Plasma exchange is widely…
- 血漿プロテアーゼC1阻害剤治療の世界市場（～2026年） This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising p…
- プラズマアーク切断の世界市場（～2026年） Market Analysis and Insights: Global Plasma Arc Cutting Market The global Plasma Arc Cutting market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes…